No Data
No Data
New stock news: Aiming to become the first stock of domestic cosmetics in Hong Kong, Maoge Ping passed the hearing at the Hong Kong Stock Exchange.
According to the news from Hong Kong Stock Exchange on November 20, Mao Geping Cosmetic Co., Ltd. (referred to as Mao Geping) passed the listing hearing on the main board of the Hong Kong Stock Exchange, with China International Capital Corporation being the exclusive sponsor.
Revenue in the first half of the year was 1.972 billion yuan, leading domestic beauty brand Maogeping surges again to the Hong Kong Stock Exchange!
① Mao Ge Ping's cosmetic and skincare products have a gross margin of over 80%, but a net margin of only 20%-25%, which means that Mao Ge Ping's products are eroded by selling expenses and management expenses. ② Despite positioning itself as high-end, Mao Ge Ping does not invest much in research and development. In recent years, Mao Ge Ping's research and development expenditure rate has been around 0.8%, lower than the average research and development expense rate of 2% for cosmetic companies. And out of 49 patents, only 2 are invention patents.
IPO News | Mao Geping reports that the main board of the Hong Kong Stock Exchange is the only Chinese company among the top ten high-end beauty groups in the Chinese market
The Zhitong Finance App learned that according to the Hong Kong Stock Exchange disclosure on April 8, Mao Geping Cosmetics Co., Ltd. (Mao Geping) submitted a listing application to the main board of the Hong Kong Stock Exchange, and CICC is its sole sponsor. Mao Geping is a leading high-end beauty group in China. It is committed to providing consumers with a full range of beauty experiences through high-quality and innovative beauty products, professional makeup art training, and experiential and personalized customer service. According to Frost & Sullivan, Mao Geping is the only Chinese company among the top ten high-end beauty groups in the Chinese market, ranking 8th in terms of retail sales in 2022. According to Frost & Sullivan
No Data
No Data